Toxoplasma chorioretinitis
ICD-10 B56.1 is a billable code used to indicate a diagnosis of toxoplasma chorioretinitis.
Toxoplasma chorioretinitis is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause significant morbidity, particularly in immunocompromised individuals and during pregnancy. The condition is characterized by inflammation of the choroid and retina, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. The infection is often acquired through ingestion of oocysts found in contaminated food or water, or through contact with infected cat feces. In immunocompetent individuals, Toxoplasma chorioretinitis may remain asymptomatic or present with mild symptoms, but in those with weakened immune systems, such as patients with HIV/AIDS or those undergoing chemotherapy, the disease can be more severe. Diagnosis typically involves clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as fundus photography or optical coherence tomography. Treatment usually includes antiparasitic medications like pyrimethamine and sulfadiazine, often combined with corticosteroids to reduce inflammation. Early diagnosis and treatment are crucial to prevent complications and preserve vision.
Detailed ocular examination findings, including visual acuity and fundoscopic findings.
Patients presenting with vision changes, floaters, or eye pain.
Documentation must clearly indicate the relationship between Toxoplasma infection and ocular symptoms.
Comprehensive history of exposure, serological test results, and treatment plans.
Immunocompromised patients with systemic symptoms and ocular involvement.
Need to document the patient's immune status and any concurrent infections.
Used when a new patient presents with symptoms suggestive of Toxoplasma chorioretinitis.
Complete ocular examination findings and patient history.
Ophthalmologists should document specific findings related to Toxoplasma infection.
Common symptoms include blurred vision, floaters, eye pain, and in severe cases, vision loss. Patients may also experience systemic symptoms if the infection is widespread.
